Increased DNA Synthetic Potency of Hepatocytes in Cirrhotic Patients May Indicate a Super-High Risk for Hepatocellular Carcinoma
Bromodeoxyuridine (BrdU) labeling indices (LI) of liver biopsied specimens from 27 control liver cirrhosis patients (control LC) without hepatocellular carcinoma (HCC), 26 cirrhotic patients with HCC, and from 6 control subjects were examined using an in vitro BrdU labeling technique. The mean BrdU...
Gespeichert in:
Veröffentlicht in: | Japanese Journal of Medicine 1990, Vol.29(4), pp.373-378 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Bromodeoxyuridine (BrdU) labeling indices (LI) of liver biopsied specimens from 27 control liver cirrhosis patients (control LC) without hepatocellular carcinoma (HCC), 26 cirrhotic patients with HCC, and from 6 control subjects were examined using an in vitro BrdU labeling technique. The mean BrdU LI±S.E. of HCC cancerous portion, HCC non-cancerous cirrhotic portion, control LC, and control subjects were 6.6±0.8%, 2.7±0.3%, 1.7±0.3% and 0.25±0.09%, respectively. Interestingly, there was a significant difference (p |
---|---|
ISSN: | 0021-5120 1881-123X |
DOI: | 10.2169/internalmedicine1962.29.373 |